Watch Ticker

Relmada Therapeutics, Inc. Common Stock

Go to Relmada Therapeutics, Inc. Common Stock Website

$0.56

-0.06 (-9.22%)

Live

Previous Close

$0.569

Day Range

$0.5671 - $0.61

Previous Day Range

$0.59 - $0.6189

Market Cap

$20.4 million USD

Day Vol.

195377

Previous Day Vol.

140830

Currency

USD

Primary Exchange

Nasdaq

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Corporate Communications - Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Relmada Therapeutics strengthens its clinical advisory board by appointing Dr. Yair Lotan as Clinical Advisory Board Chair and Dr. Raj S. Pruthi as CMO-Urology, supporting the development of their NDV-01 program with a planned Phase 3 trial in H1 2026.

Related tickers: RLMD.

Read Full Article

N/A - Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

Relmada Therapeutics announced positive Phase 2 data for its investigational drug NDV-01 in patients with high-grade non-muscle invasive bladder cancer. The data showed strong clinical activity and favorable tolerability, supporting further development of NDV-01.

Related tickers: RLMD.

Read Full Article

Trending Tickers

Please sign in to view